What this driver domain covers
Microbes is the broadest domain in the 5M Model. It encompasses several categories of chronic microbial contribution to illness: chronic tick-borne infections (Lyme, Bartonella, Babesia, and the less common Anaplasma, Ehrlichia, Rickettsia); chronic parasitic infections (both helminthic and protozoal); chronic viral reactivation (Epstein-Barr virus, cytomegalovirus, and the post-acute sequelae of SARS-CoV-2 — Long COVID and post-vaccine syndromes); and gut microbiome dysfunction (dysbiosis, small intestinal bacterial overgrowth, fungal overgrowth).
The unifying clinical principle is that chronic microbial drivers — whether bacterial, viral, parasitic, or compositional imbalances of normal flora — produce systemic effects through sustained immune activation, direct cellular dysfunction, and downstream metabolic and inflammatory consequences. Patients rarely present with one isolated chronic microbial issue. They present with patterns, and recognizing the patterns is the diagnostic work.
Why this domain is so frequently missed
Mainstream infectious disease medicine is built around acute infection — identifying the organism, treating it, monitoring for resolution. The infrastructure for evaluating and treating chronic, persistent, or post-infectious microbial contribution to illness is much less developed. Diagnostic testing for chronic infections has well-documented limitations. Standard Lyme serology misses a significant percentage of cases, particularly in chronic disease. Bartonella testing is notoriously poor. Standard stool studies miss many parasitic infections. Chronic viral reactivation in immunocompetent patients is rarely evaluated. Gut microbiome dysfunction is evaluated narrowly.
How chronic microbial drivers interact with other domains
Microbes rarely operate in isolation in the 5M Model. The patient with chronic Lyme almost always has downstream mast cell activation and mitochondrial dysfunction. The patient with significant gut dysbiosis often has secondary nutrient deficiencies, hormone metabolism disruption, and immune dysregulation that look like separate problems. Treating chronic microbial drivers in isolation produces partial responses that don't last. The framework approach is to identify the microbial drivers, address them appropriately, and simultaneously support the response domains that have been activated.
The condition pages that go deeper
Specific clinical detail on each major category of chronic microbial driver lives on dedicated condition pages: Tick-Borne Disease; Long COVID and Post-Vaccine Syndromes; Chronic Viral Reactivation (EBV and CMV); Parasites: Worms and Helminthic Infections; Parasites: Protozoa and Cystic Parasites; SIBO and SIFO; and Gut Dysbiosis.
Pro Tip · From Dr. Everett
The unifying clinical principle is that chronic microbial drivers — whether bacterial, viral, parasitic, or compositional imbalances of normal flora — produce systemic effects through sustained immune activation, direct cellular dysfunction, and downstream metabolic and inflammatory consequences. Patients rarely present with one isolated chronic microbial issue. They present with patterns, and recognizing the patterns is the diagnostic work.
Sources & Further Reading
- CDC: Tick-Borne Diseases of the United States cdc.gov/ticks
- NIH RECOVER: Long COVID Research Initiative recovercovid.org
- CDC: Epstein-Barr Virus and Infectious Mononucleosis cdc.gov/epstein-barr
- HHS Tick-Borne Disease Working Group hhs.gov/ash/advisory-committees/tickbornedisease
Concerned this applies to you?
A consultation is where we figure out whether microbes is actually contributing to your symptoms — and what to do about it.